ApprovalTrail

Drug · DIN 02330989

MULTAQ

FILM-COATED TABLET

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since September 28, 2009; first marketed September 28, 2009.
Drug Identification Number (DIN)
02330989
Company (DIN owner)
Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Dronedarone C01BD07
Class
Human
Record last updated
August 6, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DRONEDARONE (DRONEDARONE HYDROCHLORIDE)400 MG

Notices of Compliance

Health Canada approvals that name this DIN.

Recalls and safety alerts that mention it

Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “multaq”. A notice may cover another product or only some lots: read it to see what it covers.